Global Clot Management Devices Market Regional Analysis
North America is expected to hold a dominant position in the global clot management devices market over the forecast period, owing to frequent research and development activities in the region.
For instance, in April 2019, Tufts Medical Center in Boston and Eskenazi Health, a partner with the Indiana University School of Medicine, are developing a Mobile Active Compression (MAC) calf device for prevention of deep vein thrombosis. MAC is light-weight and portable device, which can be worn around limbs, as limbs have higher risk of deep vein thrombosis. Such innovations associated with clot management devices are expected to accelerate the global clot management devices market growth.
Clot Management Devices Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients